Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
116.80 USD  -0.29 (-0.25%)
Official Closing Price  /  Updated: 7:49 PM EST, Jan 16, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,920,500
Open 116.99
Bid (Size) 115.00 (3)
Ask (Size) 118.15 (1)
Prev. Close 117.09
Today's Range 116.48 - 118.07
52wk Range 73.69 - 119.84
Shares Outstanding 1,085,430,420
Dividend Yield 1.93%
Performance
YTD
+1.67%
+1.67%
1 Month
+7.79%
+7.79%
3 Month
+2.83%
+2.83%
6 Month
+29.73%
+29.73%
1 Year
+36.94%
+36.94%
Top News
More News
UPDATE 2-Amgen's postmenopausal osteoporosis drug wins FDA panel backing
An advisory panel to the U.S. Food and Drug Administration said on Wednesday that benefits of Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture outweighed its risks... Read More
category companyNews
from Reuters: Company News
Ligand Pharmaceuticals stock tanks after extremely critical Citron report
Shares of Ligand Pharmaceuticals Inc. fell 17% on Wednesday after Citron Research, headed by famed short seller Andrew Left, called the drug company’s pipeline a ‘pipe dream.’ Read More
category M&A , Company Announcements , RTRX , and 11 more.
from MarketWatch
More News
Read More
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Regarding Whether the Sale of Loxo Oncology, Inc. to Eli Lilly and Company is Fair to Shareholders
from GlobeNewswire News Releases
Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It
from Investor's Business Daily
U.S. lawmaker launches investigation into pharma drug pricing
category companyNews
from Reuters: Company News
Takeda Wraps Its Shire Buyout, CEO Sees More Mergers Coming
from Investor's Business Daily
Why Yet Another Biotech Stock Is Grabbing Renewed Takeover Chatter
from Investor's Business Daily
House Democrats launch drug pricing probe into a dozen major health-care companies
category Mallinckrodt Plc , Teva Pharmaceutical Industries Ltd , Medical biotechnology industry , and 16 more.
from CNBC.com News
House Democrats launch probe into drug prices
category ABBV , Medical Products , SNY , and 9 more.
from MarketWatch
Biotech is in the midst of major breakout, but one technician says buyer beware
category Biotechnology , Celgene Corp , Investing , and 6 more.
from CNBC.com News
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
category ZLAB , EXEL , AMGN , and 19 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.